UK markets close in 8 hours 25 minutes

Arch Therapeutics, Inc. (ARTH)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.9500+0.0250 (+2.70%)
At close: 03:40PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Total revenue
115.33
75.724
15.652
11.565
0
Cost of revenue
84.134
78.163
51.489
26.282
0
Gross profit
31.196
-2.439
-35.837
-14.717
0
Operating expenses
Research development
715.007
670.88
1,153
1,353
1,611
Selling general and administrative
4,580
4,371
4,520
5,009
3,741
Total operating expenses
5,295
5,042
5,673
6,362
5,352
Operating income or loss
-5,263
-5,044
-5,709
-6,377
-5,352
Interest expense
3,759
3,097
567.048
150.531
18.534
Total other income/expenses net
-
1,158
1,000
287.173
679.271
Income before tax
-7,864
-6,983
-5,276
-6,240
-4,691
Income from continuing operations
-7,864
-6,983
-5,276
-6,240
-4,691
Net income
-7,864
-6,983
-5,276
-6,240
-4,691
Net income available to common shareholders
-7,864
-6,983
-5,276
-6,240
-4,691
Basic EPS
-4.72
-2.27
-4.40
-6.00
-4.00
Diluted EPS
-4.72
-2.27
-4.40
-6.00
-4.00
Basic average shares
1,260
3,074
1,200
1,100
940.258
Diluted average shares
1,260
3,074
1,200
1,100
940.258